U.S. Congestive Heart Failure Device Markets : Market Research Report

U.S. Congestive Heart Failure Device Markets

Published: Mar. 18, 2006

1. Executive Summary
1. Executive Summary
1. Executive Summary Presentation

2. Introduction and Overview
1. Introduction
  1. Scope and Segmentation
2. Definitions and Abbreviations
  1. List of Abbreviations
  2. Definitions
3. Overview of Congestive Heart Failure
  1. Review of Congestive Heart Failure
  2. Classification of Congestive Heart Failure

3. Total U.S. Congestive Heart Failure Device Market
1. Market Overview
  1. Introduction
  2. Industry Challenges
  3. Strategic Recommendations
2. Market Trends
  1. Market Drivers
  2. Market Restraints
3. Market Forecasts and Analysis
  1. Market Engineering Measurements
  2. Total Revenue Forecasts
  3. Unit Shipment Forecasts
  4. Unit Pricing
4. Competitive Analysis
  1. Competitive Structure
  2. Distribution Channels
  3. Market Share Analysis
5. Frost & Sullivan Awards for U.S. Congestive Heart Failure
      Device Market
  1. Technology Leadership Award
  2. Vertical Market Penetration Leadership Award
  3. Product Innovation Award
  4. Technology Innovation Award

4. U.S. Cardiac Resynchronization Therapy Market
1. Introduction and Overview
  1. Introduction
  2. Device Options
  3. Impact of Device Recalls
2. Market and Technology Trends
  1. Market Trends
  2. Technology Trends
3. Market Forecasts and Analysis
  1. Market Engineering Measurements
  2. Revenue Forecasts
  3. Unit Shipment Forecasts
  4. Unit Pricing
4. Competitive Analysis
  1. Competitive Structure
  2. Market Share Analysis

5. U.S. Ventricular Assist Device Market
1. Introduction and Overview
  1. Indications and Demand
  2. Classification and Types
  3. Device Options
2. Market and Technology Trends
  1. Market Trends
  2. Technology Trends
3. Market Forecasts and Analysis
  1. Market Engineering Measurements
  2. Revenue Forecasts
  3. Unit Shipment Forecasts
  4. Unit Pricing
4. Competitive Analysis
  1. Competitive Structure
  2. Market Share Analysis

6. Overview of Alternate Congestive Heart Failure Devices
1. Comprehensive Review
1. Device Options
2. Technology Trends

7. Emerging Technologies
1. Emerging Technologies
1. Congestive Heart Failure Devices

8. Appendix
1. Decision Support Databases
  1. Incidence of Myocardial Infarction
  2. Prevalence of Hypertension
  3. Coronary Heart Disease Mortality
  4. Myocardial Infarction Mortality
  5. Number of Registered Cardiologists
  6. Number of Hospitals
  7. Number of Heart Transplants

List of Figures

Chapter 3

Total Congestive Heart Failure Device Therapy Market: Impact of Top Industry Challenges (U.S.), 2006-2012

Total Congestive Heart Failure Device Therapy Market: Strategic recommendations (U.S.), 2006-2012

Total Congestive Heart Failure Device Therapy Market: Market Drivers Ranked in the Order of Impact (U.S.), 2006-2012

Total Congestive Heart Failure Device Therapy Market: Market Restraints Ranked in the Order of Impact (U.S.), 2006-2012

Total Congestive Heart Failure Device Therapy Market: Revenue Forecasts (U.S.), 2002-2012

Total Congestive Heart Failure Device Therapy Market: Unit Shipment Forecasts (U.S.), 2002-2012

Total Congestive Heart Failure Device Therapy Market: Pricing Trends (U.S) 2002-2012

Total Congestive Heart Failure Device Therapy Market: Competitive Structure (U.S.), 2005

Chapter 4

CRT-P Segment in the Cardiac Resynchronization Therapy Market: Revenue Forecasts (U.S.), 2002-2012

CRT-D Segment in the Cardiac Resynchronization Therapy Market: Revenue Forecasts (U.S.), 2002-2012

CRT-P Segment in the Cardiac Resynchronization Therapy Market: Unit Shipment Forecasts (U.S.), 2002-2012

CRT-D Segment in the Cardiac Resynchronization Therapy Market: Unit Shipment Forecasts (U.S.), 2002-2012

Total Cardiac Resynchronization Therapy Market: Pricing Trends (U.S), 2002-2012

Total Cardiac Resynchronization Therapy Market: Competitive Structure (U.S.), 2005

Chapter 5

Ventricular Assist Device Market: Revenue Forecasts (U.S.), 2002-2012

Ventricular Assist Device Market: Unit Shipment Forecasts (U.S.), 2002-2012

Ventricular Assist Device Market: Pricing Trends (U.S.), 2002-2012

Ventricular Assist Device Market: Competitive Structure (U.S.), 2005

Abstract

Research Overview

This Frost & Sullivan research service entitled U.S. Congestive Heart Failure Device Markets provides an overview of alternate treatment options in the U.S. markets for the treatment of CHF along with a complete analysis of key market drivers, restraints, and trends. In this research service, Frost & Sullivan's expert analysts thoroughly examine the U.S cardiac resynchronization therapy (CRT) and ventricular assist devices (VAD) markets.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

Cardiac resynchronization therapy (CRT) market
Ventricular assist devices (VAD) market

Market Overview

Congestive Heart Failure Devices to face Stiff Competition from Drug Industry

The acceptance and usage of congestive heart failure (CHF) devices when compared to drugs have been relatively slow over the past few years. In addition to drug therapy, less-invasive procedures such as mitral valve repair and ventricular restoration pose a challenge to CHF device manufacturers. However, even with intensive pharmacological and lifestyle therapy, the mortality rate due to CHF remains high. Considering the heavy investment in scientific research as well as the direct and indirect costs of therapy and workdays associated with CHF, device manufacturers now have the ideal opportunity to offer alternative treatment methods.

The majority of the revenue potential is in some of the niche areas, especially the end-user segment favoring the drug industry. "A combination of device and drug is expected to pave the way for a slow but steady progress into this domain," explains the analyst of this research service. "The company that taps into this market segment successfully is more likely to establish a greater stronghold in the CHF market due to the immense popularity of drugs, combined with the technological strength of mechanical devices."

Timely FDA Approvals Essential to Remain Competitive

Competition is on the rise in the U.S. CHF devices markets and manufacturers need to have strong marketing and sales strategies in place to succeed in this field. Already, a large number of devices are in the pipeline and at various stages of development or are awaiting approval from the U.S. Food and Drug Administration (FDA). "CHF device vendors compete for every resource that is likely to boost sales once their devices are approved by the FDA, whether it is high-profile clinical trials or publicized endorsements by expert cardiologists supervising them," says the analyst.

Gaining quick and timely FDA approval is proving to be a strong challenge for CHF device manufacturers due to stricter regulations and safety standards. While delay in market entry is a significant issue, the long-term success of a device hinges on superior performance, safety features, and end-user confidence. Popularity of large-base clinical trials such as the SCD-HeFT, CARE-HF, COMPANION, and MIRACLE series are playing an important role in establishing the relevance and efficacy of devices in CHF treatment. The proven benefits of various devices such as biventricular pacemakers and implantable cardioverter defibrillators (collectively, cardiac resynchronization therapy) are also likely to increase prescription support for CHF devices.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

advertise with us

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

U.S. Congestive Heart Failure Device Markets

Table of Contents

Abstract